About Us
Our vision is to map drug-binding capacities for disordered proteins, catalysing next-generation drug discovery.
Our vision is to map drug-binding capacities for disordered proteins, catalysing next-generation drug discovery.
Overview
We are first building a high-throughput, parallel platform to probe millions of small-molecule/disordered protein interactions.
We will leverage this platform (combining cellular and biophysical experiments, computation, and AI) to create an enormous dataset and ultimately build an AI system that, given any disordered protein sequence, will predict promising drug candidates.
Our Vision
The scale of our science is bold, requiring a strong engineering focus, and is rooted in public benefit.
To maximise impact, we have established Bind as a Focused Research Organisation (FRO), the first to be formed in the UK. We are committed to sharing our output (tools, AI software and data) publicly, while also maximising translational impact by protecting IP of specific, potential drug molecules to ensure they can be developed into therapeutics and ultimately accessed by medical professionals and patients.
Our Culture
We strive to advance disordered protein research by creating and sharing tools and datasets collaboratively.
We believe the most effective solutions come from a dynamic, adaptable mindset that embraces uncertainty as a catalyst for discovery, encouraging creativity, challenging assumptions, and approaching problems from multiple angles to foster innovation, navigate complexity, and deliver exceptional results.
Our Expertise
A diverse, experienced, and collaborative team.
Our team’s expertise spans academic, industrial, and startup experience across many diverse scientific areas, with a strong engineering mindset.
